Current targets: Where are we today?

Heart

Volumn 89, Issue SUPPL. 2, 2003, Pages

  Pringle, Michael ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CERIVASTATIN; CHOLESTEROL; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; PRAVASTATIN; SIMVASTATIN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; GENERAL PRACTICE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SMOKING CESSATION; WORKLOAD;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; FAMILY PRACTICE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; WORKLOAD;

EID: 0242584517     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Hammersley V, Hippisley-Cox J, Wilson A, et al. A comparison of research general practices and their patients with other practices - a cross-sectional study in Trent. Br J Gen Pract 2002;52:463-8.
2. Hippisley-Cox J, Pringle M. General practice workload implications of the national service framework for coronary heart disease: cross sectional survey. BMJ 2001;323:269-70.
3. Department of Health. National service framework for coronary heart disease. London: Department of Health, 2000.
4. Ramsay LE, Williams B, Johnston GD, et al, for the British Hypertension Society. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens 1999;13:569-92.
5. Hippisley-Cox J, Cater C, Pringle M, et al. A cross-sectional survey of the effectiveness of lipid lowering drugs in lowering serum cholesterol in 17 general practices. BMJ (in press).
6. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994;344:1383-9.